BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10766580)

  • 1. [Dihydropyrimidine dehydrogenase and thymidylate synthase activities in colonic cancer tissue and sensitivity to 5-fluorouracil].
    Araki S; Isomoto H; Matsumoto A; Kaihara J; Yasunaga M; Hayashi K; Yatsugi H; Yamauchi K
    Nihon Geka Gakkai Zasshi; 1999 Dec; 100(12):822. PubMed ID: 10766580
    [No Abstract]   [Full Text] [Related]  

  • 2. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
    Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
    Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biological analysis of 5-fluorouracil sensitivity in colorectal neoplasm].
    Kubota T; Yoshinare K; Kabeshima Y; Watanabe M; Kitajima M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():321-4. PubMed ID: 14574903
    [No Abstract]   [Full Text] [Related]  

  • 6. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer.
    Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T
    J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
    Kirihara Y; Yamamoto W; Toge T; Nishiyama M
    Int J Oncol; 1999 Mar; 14(3):551-6. PubMed ID: 10024690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dihydropyrimidine dehydrogenase and thymidylate synthase in colon carcinoma].
    Hamaji M; Nishida T; Miyazaki S; Nishida Y
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):889-93. PubMed ID: 12090040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Fukushima M; Minamigawa K; Takano T; Kobayashi H
    Lung Cancer; 2001 Dec; 34(3):407-16. PubMed ID: 11714538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer.
    Inoue T; Hibi K; Nakayama G; Komatsu Y; Fukuoka T; Kodera Y; Ito K; Akiyama S; Nakao A
    J Gastroenterol; 2005 Feb; 40(2):143-7. PubMed ID: 15770397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients.
    Mauritz R; Beumer IJ; Marsh S; McLeod HL; Smid K; van Groeningen CJ; Pinedo HM; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1381-4. PubMed ID: 15571263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human tumor sensitivity to 5-fluorouracil influenced by dihydropyrimidine dehydrogenase mRNA in the tumor].
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Kumai K; Kitajima M
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):274. PubMed ID: 9750075
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
    Inada T; Ogata Y; Kubota T; Tomikawa M; Yamamoto S; Andoh J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
    Anticancer Res; 2000; 20(4):2457-62. PubMed ID: 10953310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Inoue K; Takao M; Watanabe F; Tarukawa T; Shimamoto A; Kaneda M; Sakai T; Fukushima M; Shimpo H; Yada I
    Lung Cancer; 2005 Jul; 49(1):47-54. PubMed ID: 15949589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxins and cancer immunotherapy: the dance of the macabre?
    Allegra CJ; Childs RW
    J Natl Cancer Inst; 2005 Oct; 97(19):1396-7. PubMed ID: 16204684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
    Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
    Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.